Hemoblast Bellows
Payments companies reported to CMS as associated with Hemoblast Bellows. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hemoblast Bellows, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hemoblast Bellows
These are the largest totals companies reported as associated with Hemoblast Bellows. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Abhishek Chatterjee | Lebanon, NH | Surgery | $131,787.88 |
| Lynt Johnson | Washington, DC | Transplant Surgery | $129,339.55 |
| Young Hong | Camden, NJ | Surgery | $90,912.63 |
| Kahyun Yoon-Flannery | Hammonton, NJ | Surgery | $49,205.93 |
| David Rivadeneira | Woodbury, NY | Colon & Rectal Surgery | $48,294.87 |
| Oliver Eng | Orange, CA | Surgical Oncology | $27,249.00 |
| Aslam Ejaz | Chicago, IL | Surgical Oncology | $14,679.44 |
| Gregory Veillette | Valhalla, NY | Transplant Surgery | $14,054.64 |
| Edward Soltesz | Cleveland, OH | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $13,691.42 |
| Daniel Lubelski | Baltimore, MD | Surgery | $10,661.77 |
Prescribed Hemoblast Bellows?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.